| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 07/31/2007 | CA2333603C New dipeptidyl peptidase iv effectors |
| 07/31/2007 | CA2077763C Use of leukaemia inhibitory factor for regulating neuron development and maintenance |
| 07/26/2007 | WO2007083823A1 Androgen receptor-binding activity of genoderma mushroom-treated product |
| 07/26/2007 | WO2007083689A1 Plasminogen activator inhibitor-1 inhibitor |
| 07/26/2007 | WO2007083640A1 Preventive or remedy for increased urinary frequency and urinary incontinence |
| 07/26/2007 | WO2007082967A1 A method for identifying a renal fibrosis process, use of snail-activity-inhibiting compounds in the production of pharmaceutical compositions, method for identifying said inhibiting compounds, said pharmaceutical compositions and applications thereof |
| 07/26/2007 | WO2007082914A2 Method of diagnosis and method of treatment |
| 07/26/2007 | WO2007058971A3 Soft anticholinergic esters |
| 07/26/2007 | WO2006122154A3 Pyridone derivatives for modulating stress-activated protein kinase system |
| 07/26/2007 | US20070174924 Transgenic mice containing TRP gene disruptions |
| 07/26/2007 | US20070173518 Crystal of ticagrelor; G-protein coupled receptor antagonist, used for treating arterial thrombotic complications |
| 07/26/2007 | US20070173454 Administering an agent that decreases or regulates the blood level, production, function or activity of gonadotropins-leutinizing hormone, follicle stimulating hormone, activin or follistatin; parkinson's disease |
| 07/26/2007 | US20070172532 Complex Mixtures Exhibiting Selective Inhibition of Cyclooxygenase-2 |
| 07/26/2007 | US20070172450 Modulation of immune response and methods based thereon |
| 07/26/2007 | US20070172447 Agent for preventing and/or treating tissue disruption-accompanied diseases |
| 07/26/2007 | US20070172444 Hair tonics and method of screening the same |
| 07/26/2007 | CA2637609A1 A method for identifying a renal fibrosis process, use of snail-activity-inhibiting compounds in the production of pharmaceutical compositions, method for identifying said inhibiting compounds, said pharmaceutical compositions and applications thereof |
| 07/25/2007 | EP1810979A1 STABILIZED HUMAN IgG4 ANTIBODIES |
| 07/25/2007 | EP1810715A2 Combination comprising an agent decreasing VEGF activity and an agent decreasing EGF activity |
| 07/25/2007 | EP1810673A1 Therapeutic agent for interstitial cystitis |
| 07/25/2007 | EP1809316A1 Use of survivin to treat kidney failure |
| 07/25/2007 | EP1809305A2 Phosphate binder with reduced pill burden |
| 07/25/2007 | EP1809271A2 (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 07/25/2007 | EP1499600B1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 07/25/2007 | EP1397364B1 Novel pyrrole derivatives as pharmaceutical agents |
| 07/25/2007 | EP1383502A4 Compounds and methods for the treatment of urogenital disorders |
| 07/25/2007 | EP1282610B1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 07/25/2007 | CN1328260C Beta crystalline form of perindopril tert-butylamine salt, preparation method and pharmaceutical compositions containing same |
| 07/25/2007 | CN1328259C Alpha crystalline form of perindopril tert-butyllamine salt |
| 07/25/2007 | CN1328258C Gamma crystalline form of perindopril tert-butylamine salt, preparation method and pharmaceutical compositions containing same |
| 07/25/2007 | CN1328247C N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 07/25/2007 | CN1327874C Chinese medicine formulation for treating chronic prostatitis and its preparing method |
| 07/25/2007 | CN1327831C Method for preparing drug material of swertiamarin |
| 07/25/2007 | CN101006047A TRPV1 agonists, formulations containing them and uses thereof |
| 07/25/2007 | CN101003573A Human antibodies that bind human tnfalpha |
| 07/25/2007 | CN101002940A Medicine composition for treating polycystic renal disease |
| 07/25/2007 | CN101002906A Compounding traditional Chinese medicine, and its use |
| 07/25/2007 | CN101002840A Medicine for treating calculosis, and its preparing method |
| 07/25/2007 | CN101002801A Health-care food for enhancing immunity, and its preparing method |
| 07/25/2007 | CN101002796A Application of nanometer montmorillonite for pharmaceutical use, and medicine compositions therewith |
| 07/25/2007 | CN101002795A Method for preparing dialysis dry powder and dialysate of pure sodium bicarbonate |
| 07/25/2007 | CN101002760A Application of chlorogenic acid for preparing medicine to treat diabetes complications |
| 07/25/2007 | CN101002632A Nanometer traditional Chinese medicine and electromagnetic briefs |
| 07/25/2007 | CN101002589A Health-care medicine tea for sobering and taking care of liver and kidney |
| 07/25/2007 | CN101002588A Medicine tea for cleaning away kidney stone and choleithiasis |
| 07/24/2007 | US7247639 Xanthines 1-substituted with an alkyl group, 3-substituted with a phenylalkylene group and 8-substituted with an arylalkylene group, e.g. 3-[2-[4-(5-aminopentyl-3-amidocarboxypropanoyl)]aminophenyl]ethyl]-8-benzyl-7-[2-ethyl(2-hydroxyethyl)amino]ethyl-1-propylxanthine |
| 07/24/2007 | US7247633 Pyrimidine compounds and their use |
| 07/24/2007 | US7247624 e.g. 5-Benzyloxy-2-(4-benzyloxy-phenyl)-3-methyl-1H-indole or salts for treating colon cancer |
| 07/24/2007 | US7247615 Nucleic acid encoding peptides which antagonist epitope against prostate specific antigen; anticancer agents |
| 07/19/2007 | WO2007081030A1 Pyrrolopyridazinone compound |
| 07/19/2007 | WO2007080776A1 Sustained release preparation and method for production thereof |
| 07/19/2007 | WO2007080109A1 Substituded benzyloxy-phenylmethylurea derivatives |
| 07/19/2007 | WO2007079695A1 An extract of xanthoceras sorbifolia bunge and extraction and uses thereof |
| 07/19/2007 | WO2006037623A3 New nuclear transcription factors regulators |
| 07/19/2007 | US20070167511 Medicinal composition for prevention or treatment of overactive bladder accompanying nervous disorder |
| 07/19/2007 | US20070167503 Substituted benzoxazoles as estrogenic agents |
| 07/19/2007 | US20070167501 Bicyclo derivative |
| 07/19/2007 | US20070167500 Remedy for urinary tract diseases |
| 07/19/2007 | US20070167498 Carboxylic acid compounds |
| 07/19/2007 | US20070167493 Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation, therapeutic and cosmetic uses thereof |
| 07/19/2007 | US20070167457 2-(2-(4-Fluoro)phenoxyethyl)-1-((4-(2-methyl-5-phenyl)thiazolyl)carbonyl)-4-trifluoroacetylpiperazine; antidiabetic agent; non-insulin dependent diabetes, obesity, sleep disorder |
| 07/19/2007 | US20070167445 Androgen receptor modulator compounds and methods |
| 07/19/2007 | US20070167444 Benzamide derivative or salt thereof |
| 07/19/2007 | US20070167429 such as 2Z)-N-(2-hydroxyethyl)-2-{4,4,7-trifluoro-1-[4-{[(2S)-2-fluoropropyl]oxy}-2-(trifluoromethyl)benzoyl]-1,2,3,4-tetrahydro-5H-1-benzazepin-5-ylidene}acetamide, for treating or preventing urinary incontinence and/or diabetes |
| 07/19/2007 | US20070167373 Combined use of a GLP-1 compound and a modulator of diabetic late complications |
| 07/19/2007 | US20070166376 Solid pharmaceutical preparation |
| 07/19/2007 | CA2637388A1 Pyrrolopyridazinone compound |
| 07/19/2007 | CA2632962A1 Sustained release preparation and method for production thereof |
| 07/18/2007 | EP1808484A1 Nuclear transfer with differentiated fetal and adult donor cells |
| 07/18/2007 | EP1808172A2 Botanical extract compositions and methods of use |
| 07/18/2007 | EP1807429A2 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 07/18/2007 | EP1807065A2 Methods and compositions for treating nephrogenic diabetes insipidus |
| 07/18/2007 | EP1558598B1 Triazole compounds for the treatment of dysmenorrhoea |
| 07/18/2007 | EP1150678B1 Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 07/18/2007 | EP1139753B1 Formulations for treating disease and methods of using same |
| 07/18/2007 | CN1326563C Use of the long pentraxin PTX3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
| 07/18/2007 | CN1326560C Use of POLY-GLU,TYR treated therewith for neuroprotective therapy |
| 07/18/2007 | CN1326539C Inflammation diminishing capsule and its preparing process |
| 07/18/2007 | CN101001857A 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones |
| 07/18/2007 | CN100999519A (-) poly thaazoleazine methylsulfonate, its preparation process and use |
| 07/18/2007 | CN100998869A Anti-angiogene compositions and methods of use |
| 07/18/2007 | CN100998852A Chinese medicinal health-care preparation for cloaring lung, supplementing kidney |
| 07/18/2007 | CN100998836A Medicine for treating multi-organ lithiasis and its preparation method |
| 07/18/2007 | CN100998822A Medicinal composition for treating chronic kidney region fibrosis and its preparation method |
| 07/18/2007 | CN100998797A Chinese medicinal composition for treating urinamid |
| 07/18/2007 | CN100998702A Herb soup for dispelling stones |
| 07/18/2007 | CN100998689A Traditional Chinese medicine preparation for treating chronic nephritis, kidney failure |
| 07/18/2007 | CN100998632A Method for processing Chinese herb medicine-cornel |
| 07/18/2007 | CN100998631A Medicine form of low toxin thunder godvine extract by using new processing method |
| 07/18/2007 | CN100998625A Medicine for treating calculosis |
| 07/18/2007 | CN100998565A Anti-angiogene compositions and methods of use |
| 07/18/2007 | CN100998371A Feed additive containing the fruit of Chinese wolfberry |
| 07/18/2007 | CN100998362A Chewing gum containing cranberry composition |
| 07/17/2007 | US7244753 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 07/17/2007 | US7244730 Thrombin receptor antagonists; safety, specificity, oral efficacy |
| 07/17/2007 | US7244722 5-HT2A receptor related disorders; such as 1-(2-(2-fluoro-4-nitrophenoxy)ethyl)-3-(1piperazinyl)-2(1H)-pyrazinone |
| 07/17/2007 | US7244429 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 07/17/2007 | CA2395558C Intermediates for 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 07/17/2007 | CA2321369C Dosing regimens for lasofoxifene |
| 07/17/2007 | CA2298445C Method and compositions for treating late phase allergic reactions and inflammatory diseases |